These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38524772)

  • 1. Cost effectiveness analysis for commonly used human cell and tissue products in the management of diabetic foot ulcers.
    Nherera LM; Banerjee J
    Health Sci Rep; 2024 Mar; 7(3):e1991. PubMed ID: 38524772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydrated human amnion/chorion membrane to treat venous leg ulcers: a cost-effectiveness analysis.
    Tettelbach WH; Driver V; Oropallo A; Kelso MR; Niezgoda JA; Wahab N; Jong JL; Hubbs B; Forsyth RA; Magee GA; Steel P; Cohen BG; Padula WV
    J Wound Care; 2024 Mar; 33(Sup3):S24-S38. PubMed ID: 38457290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.
    Guest JF; Atkin L; Aitkins C
    Int Wound J; 2021 Dec; 18(6):889-901. PubMed ID: 33827144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting.
    Kirsner RS; Sabolinski ML; Parsons NB; Skornicki M; Marston WA
    Wound Repair Regen; 2015 Sep; 23(5):737-44. PubMed ID: 26100572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers.
    Ananian CE; Dhillon YS; Van Gils CC; Lindsey DC; Otto RJ; Dove CR; Pierce JT; Saunders MC
    Wound Repair Regen; 2018 May; 26(3):274-283. PubMed ID: 30098272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers.
    Rice JB; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Skornicki M; Margolis DJ; Parsons NB
    J Med Econ; 2015; 18(8):586-95. PubMed ID: 25786331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hypothermically stored amniotic membrane on diabetic foot ulcers: a multicentre retrospective case series.
    Sanchez A; Hartstein A; Ashry H; Raza M
    J Wound Care; 2024 Mar; 33(Sup3):S16-S23. PubMed ID: 38457306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment.
    Tettelbach WH; Armstrong DG; Chang TJ; Jong JL; Glat PM; Hsu JH; Kelso MR; Niezgoda JA; Labovitz JM; Hubbs B; Forsyth RA; Cohen BG; Reid NM; Padula WV
    J Wound Care; 2022 Feb; 31(Sup2):S10-S31. PubMed ID: 35148642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
    Kraus I; Sabolinski ML; Skornicki M; Parsons NB
    Wounds; 2017 May; 29(5):125-132. PubMed ID: 28570252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.
    Sabolinski ML; Capotorto JV
    J Comp Eff Res; 2019 Oct; 8(14):1229-1238. PubMed ID: 31407588
    [No Abstract]   [Full Text] [Related]  

  • 11. Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study.
    Carter MJ
    J Med Econ; 2020 Nov; 23(11):1273-1283. PubMed ID: 32729342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers.
    Serena TE; Yaakov R; Moore S; Cole W; Coe S; Snyder R; Patel K; Doner B; Kasper MA; Hamil R; Wendling S; Sabolinski ML
    J Comp Eff Res; 2020 Jan; 9(1):23-34. PubMed ID: 31691579
    [No Abstract]   [Full Text] [Related]  

  • 14. The Use of Micronized Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers: A Case Series.
    Hawkins B
    Wounds; 2016 May; 28(5):152-7. PubMed ID: 27191173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreserved Placental Membranes Containing Viable Cells Result in High Closure Rate of Nonhealing Upper and Lower Extremity Wounds of Non-Diabetic and Non-Venous Pathophysiology.
    Johnson EL; Saunders M; Thote T; Danilkovitch A
    Wounds; 2021 Feb; 33(2):34-40. PubMed ID: 33591930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Skin Regeneration Using a Novel Amniotic-derived Tissue Graft.
    Mowry KC; Bonvallet PP; Bellis SL
    Wounds; 2017 Sep; 29(9):277-285. PubMed ID: 28933697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Cellular, Acellular, and Matrix-like Products and Indirect Treatment Comparison Between Cellular/Acellular and Amniotic/Nonamniotic Grafts in the Management of Diabetic Foot Ulcers.
    Banerjee J; Lasiter A; Nherera L
    Adv Wound Care (New Rochelle); 2024 Jul; ():. PubMed ID: 38780758
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative outcomes analysis evaluating clinical effectiveness in two different human placental membrane products for wound management.
    Johnson EL; Marshall JT; Michael GM
    Wound Repair Regen; 2017 Jan; 25(1):145-149. PubMed ID: 27997744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Dehydrated Human Amnion Chorion Membrane in the Treatment of Diabetic Foot Ulcers: A Review.
    Au AS; Leung WY; Stavosky JW
    J Am Podiatr Med Assoc; 2021 Mar; 111(2):. PubMed ID: 33872365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.